mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |